Gemzar plus platinum therapy showing improved survival of nearly 40 percent

Published: 2003-10-10 06:57:00
Updated: 2003-10-10 06:57:00
Lilly Korea held a recent symposium on Gemzar (gemcitabin), a third-generation anticancer drug, at Hotel Shilla and 50 hematological specialists attended the symposium at home and abroad.

The following comprehensive results of 13 clinical studies on 4,500 patients with non-small cell lung canc...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.